iCo Therapeutics (iCo Therapeutics) EPS (Basic) : $-0.38 (TTM As of Mar. 2021)

View and export this data going back to 2009. Start your Free Trial

What is iCo Therapeutics EPS (Basic)?

iCo Therapeutics's basic earnings per share (Basic EPS) for the three months ended in Mar. 2021 was $-0.08. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2021 was $-0.38.

iCo Therapeutics's EPS (Diluted) for the three months ended in Mar. 2021 was $-0.08. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2021 was $-0.38.

iCo Therapeutics's EPS without NRI for the three months ended in Mar. 2021 was $-0.08. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2021 was -0.38.

During the past 5 years, the average EPS without NRI Growth Rate was 7.60% per year. During the past 10 years, the average EPS without NRI Growth Rate was 15.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, iCo Therapeutics's highest 3-Year average EPS without NRI Growth Rate was 58.80% per year. The lowest was -41.90% per year. And the median was 27.35% per year.

iCo Therapeutics EPS (Basic) Historical Data

The historical data trend for iCo Therapeutics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iCo Therapeutics EPS (Basic) Chart

iCo Therapeutics Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

EPS (Basic)

Get a 7-Day Free Trial

-0.30

-0.16

-0.30

-0.16

iCo Therapeutics Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
EPS (Basic)	Get a 7-Day Free Trial															-0.06	-0.15	-0.15	-	-0.08

iCo Therapeutics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

iCo Therapeutics's Basic EPS for the fiscal year that ended in Dec. 2020 is calculated as

Basic EPS (A: Dec. 2020 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1.162	-	0)	/	7.687
	=	-0.15

iCo Therapeutics's Basic EPS for the quarter that ended in Mar. 2021 is calculated as

Basic EPS (Q: Mar. 2021 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.614	-	0)	/	8.053
	=	-0.08

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.38

iCo Therapeutics (GREY:ICOTF) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

iCo Therapeutics EPS (Basic) Related Terms

Thank you for viewing the detailed overview of iCo Therapeutics's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

iCo Therapeutics (iCo Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » iCo Therapeutics Inc (GREY:ICOTF) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

777 Hornby Street, 6th Floor, Vancouver, BC, CAN, V6Z 1S4

Website

http://www.icotherapeutics.com

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between the cells of the immune system. Geographically, it operates in Canada and Australia.

iCo Therapeutics (iCo Therapeutics) Headlines

No Headlines